Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma, Large B-Cell, Diffuse × MK 2206 × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Rituximab 61 Cyclophosphamide 37 Etoposide 16 Doxorubicin 16 fludarabine phosphate 15 Vincristine 15 Prednisone 15 Filgrastim 14 Mycophenolic Acid 13 Cyclosporine 12 Antilymphocyte Serum 12 Radiotherapy 10 Lenalidomide 10 Methotrexate 9 Gemcitabine 9 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Carboplatin 8 fludarabine 7 Whole-Body Irradiation 7 Melphalan 7 Cord Blood Stem Cell Transplantation 7 Busulfan 7 venetoclax 6 Ifosfamide 6 Dexamethasone 6 Bortezomib 6 ibritumomab tiuxetan 5 Methylprednisolone 5 Flow Cytometry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01466868 2014-07-10

AKTIL

Centre Leon Berard

Phase 2 Terminated

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡